Patient-specific products made from
active substances from the body.
Share in our success
Die Vaccentis AG: Sustainably
successful and innovative.
SHARE IN OUR SUCCESS
The Vaccentis AG companies have already reached key targets with various approaches to natural and conventional medicine. FBM-PHARMA has been extremely profitable on the market for years, while VCC Medical works on the basis of medicines that are already clinically proven.
SUPPORT OUR EXPANSION
Investor contributions to Vaccentis are primarily used to expand the European infrastructure and fund the authorisation procedure for VCC-001 – one of our medicines that has already proved to be effective. Furthermore, there is the opportunity to invest in new developments of modern medicines based on the well-known mode of action of already established drugs.
PROFITING IN BOTH FINANCIAL AND HUMAN RESPECTS
We promote both successful concepts with optimized business management and maximize the potential for synergies. As an investor you are profiting twice: from the financial success and the knowledge that you are helping to combat serious and extremely serious illnesses for which no, or only inadequate, treatment, has been available to date.
We will gladly provide you with further details, including facts and figures, in a personal meeting.